Back to Boston Trust Walden Corp Boston Trust Walden Corp

HALOHALO
9 quarters

Position history for Boston Trust Walden CorpBoston Trust Walden Corp's holdings in HALOZYME THERAPEUTICS INC

Boston Trust Walden Corp holds 1.1M shares of HALO (HALOZYME THERAPEUTICS INC), worth $84.8M as of 2026-Q2. The position was increased (+59.4% shares). HALO represents 0.6% of Boston Trust Walden Corp's portfolio.

Current Value

$84.8M

Current Shares

1.1M

Total Value Change

+$61.6M

Total Shares Change

+639,767

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+59.4%
$84.8M0.6%$78.27
60
2026-Q1
Decreased
679,563
-13.1%
$43.9M0.4%$69.40
0
2025-Q4
Decreased
781,835
-6.2%
$52.6M0.4%$67.70
0
2025-Q3
Decreased
833,893
-1.3%
$61.2M0.4%$73.29
0
2025-Q2
Decreased
845,246
-2.5%
$44M0.3%$52.21
0
2025-Q1
Decreased
866,872
-0.8%
$55.3M0.4%$63.84
0
2024-Q4
Increased
874,081
+28.1%
$41.8M0.3%$47.99
43
2024-Q3
Increased
682,616
+54.0%
$39.1M0.3%$56.97
49
2024-Q2
New
443,295
-
$23.2M0.2%$52.36
47

Other major holders of HALO: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used